Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma (OTEMACS)

NCT04742920 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04742920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04742920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma (OTEMACS)
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Terminated
Start date
October 12, 2021
Completion date
May 28, 2025
Enrollment
247 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

brain diseases, central nervous system diseases, hematoma, subdural, chronic, wounds and injuries